Arkolith/Insider Trading/TTNP/Form 4

Ben-Tzvi Avraham

DirectorTITAN PHARMACEUTICALS INC (TTNP) · full profile →Form 4 · filed Jul 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 26, 2023Grant(A)50K—$050K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2023Grant(A)25K—$025K
Jun 29, 2023Grant(A)100K—$0100K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-23-001765) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML